Additionally, we conducted ADME (Absorption, Distribution, Metabolism, and Excretion) and toxicity (T) analyses of the selected top dual inhibitors to find dual inhibitors of AChE and BACE1 for developing lead compounds with fewer side effects and more potency against Alzheimer’s disease. This evidence concerns the gene ACHE and Alzheimer disease.